Peer Review reports
From: A pan-cancer analysis of the oncogenic role of ERCC6L
| Original Submission | ||
|---|---|---|
| 22 Apr 2022 | Submitted | Original manuscript |
| 9 May 2022 | Reviewed | Reviewer Report - Chen Han |
| 5 Jun 2022 | Reviewed | Reviewer Report - Zhi-gang Sun |
| 13 Sep 2022 | Author responded | Author comments - Guoxin Hou |
| Resubmission - Version 2 | ||
| 13 Sep 2022 | Submitted | Manuscript version 2 |
| 30 Sep 2022 | Author responded | Author comments - Guoxin Hou |
| Resubmission - Version 3 | ||
| 30 Sep 2022 | Submitted | Manuscript version 3 |
| 7 Oct 2022 | Author responded | Author comments - Guoxin Hou |
| Resubmission - Version 4 | ||
| 7 Oct 2022 | Submitted | Manuscript version 4 |
| 13 Oct 2022 | Author responded | Author comments - Guoxin Hou |
| Resubmission - Version 5 | ||
| 13 Oct 2022 | Submitted | Manuscript version 5 |
| 5 Dec 2022 | Author responded | Author comments - Guoxin Hou |
| Resubmission - Version 6 | ||
| 5 Dec 2022 | Submitted | Manuscript version 6 |
| Publishing | ||
| 15 Dec 2022 | Editorially accepted | |
| 22 Dec 2022 | Article published | 10.1186/s12885-022-10452-3 |
You can find further information about peer review here.